ArticleThe lancet. Diabetes & endocrinology2022
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence.
Olivier Chabre et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it